Kabakoff B, Schnoes H K, DeLuca H F
Arch Biochem Biophys. 1983 Feb 15;221(1):38-45. doi: 10.1016/0003-9861(83)90119-4.
The ability of four vitamin D analogs to inhibit the liver microsomal vitamin D-25-hydroxylase was determined. 19-Hydroxy-10(S),19-dihydrovitamin D3,25-fluorovitamin D3, 3 beta-hydroxy-9,10-seco-5,7,10(19)-choletrien-24-oic acid dimethylamide and 25-aza-vitamin D3 were competitive inhibitors with apparent KI values of 44, 137, and 870 nM, and 6.4 microM, respectively. The values for the 19-hydroxy-10(S), 19-dihydrovitamin D3, 25-fluorovitamin D3, and 25-aza-vitamin D3 correspond well to other literature reports with respect to their relative in vivo inhibitory properties. 24-Oxovitamin D3 oxime also proved to be a potent inhibitor but a detailed analysis was prohibited by the lack of material. The 3 beta-hydroxy-9,10-seco-5,7,10(19)-choletrien-24-oic acid dimethylamide was also tested in vivo but had no antagonistic activity when provided at a 2000-fold excess over vitamin D3.
测定了四种维生素D类似物抑制肝微粒体维生素D-25-羟化酶的能力。19-羟基-10(S),19-二氢维生素D3、25-氟维生素D3、3β-羟基-9,10-开环胆甾-5,7,10(19)-三烯-24-酸二甲酰胺和25-氮杂维生素D3均为竞争性抑制剂,其表观抑制常数(KI)值分别为44、137和870 nM以及6.4 μM。19-羟基-10(S),19-二氢维生素D3、25-氟维生素D3和25-氮杂维生素D3的值与其相对体内抑制特性的其他文献报道非常吻合。24-氧代维生素D3肟也被证明是一种有效的抑制剂,但由于缺乏材料,无法进行详细分析。3β-羟基-9,10-开环胆甾-5,7,10(19)-三烯-24-酸二甲酰胺也在体内进行了测试,但当以比维生素D3高2000倍的剂量给药时,没有拮抗活性。